GWPH News and Press, GW Pharmaceuticals Plc From 02/03/21

Jazz Pharmaceuticals (JAZZ) raised to overweight from neutral at Piper Sandler after announcing agreement to acquire GW Pharmaceuticals (GWPH). JAZZ down 2%.``Epidiolex is the kind of durable asset that renders the potential erosion of the oxybate franchise as less problematic, positioni...

Jazz Pharmaceutical s (NASDAQ: JAZZ) announced a $7.6 billion deal to acquire GW Pharmaceuticals (NASDAQ: GWPH) , a British biotech company focused on drugs derived from cannabis. The unexpected news sent shares of GW Pharmaceuticals soaring 46%. Under the terms of the a...

Delta, Kelowna, BC - February 3, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus ins...

Gainers: Tyme Technologies (TYME) +93%.Sino-Global Shipping America (SINO) +81%.Lizhi (LIZI) +70%.Cassava Sciences (SAVA) +48%.GW Pharmaceuticals (GWPH) +46%.CPS Technologies (CPSH) +41%.10X Capital Venture Acquisition (VCVC) +38%.Naked Brand (NAKD) +37%.SuperCom (SPCB) +34%.Am...

With its $7.2B acquisition of GW Pharmaceuticals (GWPH), Jazz Pharmaceuticals (JAZZ) has acquired more than just GW's key cannabinoid product, Epidiolex, for seizures in certain conditions.Based on preliminary figures, sales of Epidiolex were around $510M in 2020.The most advanced cannabinoid...

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and GW Pharmaceuticals plc (NASDAQ: GWPH) reported entry into a definitive agreement where Jazz will acquire GW for USD 220 per American Depositary Share as USD 200 in cash and USD 20 in Jazz ordinary shares for a total of USD 7....

Shares of GW Pharmaceuticals (NASDAQ: GWPH) were skyrocketing 46.3% as of 10:45 a.m. EST on Wednesday. The huge gain came after Jazz Pharmaceuticals (NASDAQ: JAZZ) announced plans to acquire GW for $7.2 billion. It's certainly not surprising in the least that GW Pharmace...

Gainers: Tyme Technologies (TYME) +110%, GW Pharmaceuticals (GWPH) +47%, Zynerba Pharmaceuticals (ZYNE) +39%, SELLAS Life Sciences (SLS) +38%, InMed Pharmaceuticals (INM) +15%.Losers: Vaxart (VXRT) -51%, Moleculin Biotech (MBRX) -26%...

Jazz Pharmaceuticals (JAZZ) has been talking to GW Pharmaceuticals (GWPH) for "a bit" of time before deal announced today, CNBC's David Faber said."They've looked at this deal for quite some time is my understanding, been talking for a bit," Faber said. "Unclear whether there was any sor...

Marijuana Stocks Are Heating Up The Stock Market Today We know the exotic nature of certain industries, especially if you’ve become familiar with penny stocks. Some of the unique business models are utilized, ranging from treasure hunting to luxury rail-cars. While those sort of ...